Preovulatory follicle development and luteal function in ewes immunized against a synthetic peptide sequence of the α subunit of bovine inhibin

1992 ◽  
Vol 133 (3) ◽  
pp. 413-419 ◽  
Author(s):  
B. J. McLeod ◽  
M. G. Hunter ◽  
E. C. L. Bleach ◽  
R. G. Glencross ◽  
J. H. M. Wrathall
Keyword(s):  
Synthetic Peptide ◽  
Ovulation Rate ◽  
Peptide Sequence ◽  
Corpora Lutea ◽  
Follicle Development ◽  
Preovulatory Follicle ◽  
Α Subunit ◽  
Luteal Function ◽  
The Mean

ABSTRACT Immunization against inhibin consistently results in an increase in ovulation rate in sheep, but the effects that this treatment has on follicle development are unknown. In order to determine the influence of inhibin, parameters of follicle development were assessed in ewes that had been actively immunized against a synthetic peptide homologous to the N-terminal sequence (α1–29, Tyr30) of the a subunit of bovine inhibin, a treatment that neutralizes the biological activity of endogenous inhibin. The final stages of preovulatory follicle development that culminate in ovulation were induced in seasonally anoestrous ewes, and follicles were recovered prior to the predicted time of ovulation. After priming with progestagen, inhibin-immunized and control ewes were treated with gonadotrophin-releasing hormone (GnRH) by continuous infusion (200 ng/h). The ovaries were recovered at slaughter 24 h after the start of GnRH treatment and all follicles ≥ 2·0 mm diameter were dissected out and their capacity to produce oestradiol in vitro was assessed. Further groups of similarly treated animals were blood-sampled daily to determine luteal function following GnRH-induced ovulation. The ovaries were recovered from these ewes at slaughter 10 days after the start of GnRH treatment, the corpora lutea were dissected out and their progesterone content was assessed. There were more (P < 0·01) follicles of 5–6 mm diameter (3·2 ± 0·45 (s.e.m.) compared with 1·1 ± 0·25 follicles/ewe) and more (P < 0·001) follicles of > 6 mm diameter (2·8 ± 0·56 compared with 0·9 ± 0·17 follicles/ewe) in inhibin-immunized than in control ewes. In addition, the mean number of the antral follicles that were oestrogenic was greater (P < 0·05) in immunized than in control ewes (2·8 ± 0·66 compared with 1·3 ± 0·25 follicles/ewe). In animals slaughtered 10 days after the start of GnRH treatment, mean ovulation rate was greater (3·17 ± 0·65 and 1·14 ± 0·14, P < 0·01) in inhibin-immunized ewes. Although there was more (P < 0·01) total luteal tissue/ewe in the immunized group, both the mean weight and progesterone content (ng/mg tissue) of individual corpora lutea were similar between treatment groups. Mean plasma progesterone levels increased earlier and reached higher (P < 0·01) mean concentrations in immunized than in control ewes. These results demonstrate that immunization against inhibin increases the number of preovulatory follicles during the follicular phase, and that steroidogenesis within these follicles and the resultant corpora lutea appears to be normal. Journal of Endocrinology (1992) 133, 413–419

scholarly journals 210INCREASE IN OVULATION RATE AFTER IMMUNIZATION OF MALPURA EWES AGAINST A SYNTHETIC PEPTIDE SEQUENCE OF THE ±-SUBUNIT OF BOVINE INHIBIN

2004 ◽  
Vol 16 (2) ◽  
pp. 226 ◽  
Author(s):  
S.M.K. Naqvi ◽  
P. Palta ◽  
A. Joshi ◽  
R. Gulyani ◽  
V. Paul ◽  
...  
Keyword(s):  
Repeated Measures ◽  
Synthetic Peptide ◽  
Isotonic Saline ◽  
Active Immunization ◽  
Ovulation Rate ◽  
Peptide Sequence ◽  
Corpora Lutea ◽  
Primary Immunization ◽  
High Fecundity ◽  
Α Subunit

Unlike many other breeds of sheep (e.g. Boroola, Romney or Merino) which have high fecundity, the Malpura ewe, an Indian breed of sheep, is marked by an ovulation rate of one and a low incidence of twinning. Active immunization against a number of inhibin-based synthetic peptides has been reported to increase ovulation rates in these high fecundity breeds of sheep. The objective of the present study was to explore the possibility of increasing ovulation rates in Malpura ewes by active immunization against a synthetic peptide replica of the N-terminal sequence of the bovine inhibin. Adult Malpura ewes (n=5) were actively immunized against a synthetic peptide that corresponded to the N-terminus of the α-subunit of bovine inhibin [bIα(1–29)Tyr30]. The peptide was conjugated to ovalbumin, with a peptide-to-ovalbumin ratio of around 20 moles mole−1, to increase its antigenicity. Control ewes (n=5) were immunized against ovalbumin. On the day of primary immunization, 400μg of peptide-ovalbumin conjugate or ovalbumin were dissolved in 1mL of isotonic saline, emulsified with an equal volume of Freund’s complete adjuvant and injected at four sites in each ewe. Following this, boosters 1, 2 and 3 were given on Days 28, 56 and 84, respectively, of the experiment (Day 0=day of primary immunization); boosters were 200μg of peptide-ovalbumin conjugate or ovalbumin dissolved in 1mL of isotonic saline and emulsified with an equal volume of Freund’s incomplete adjuvant. Estrus was synchronized by a double injection schedule of PGF2α (7.5mg Lutalyse, once each on Days 35 and 45). The animals were subsequently allowed to undergo normal cyclicity until the end of the experiment. Ovulation rate was determined by counting the number of corpora lutea observed during laparoscopic examinations approximately 5 days after estrus during three estrous cyles following treatment. The ovulation rate between control and immunized groups was compared by repeated measures ANOVA. Immunization of the Malpura ewes against the synthetic peptide sequence of the α-subunit of bovine inhibin [bIα(1–29)Tyr30] increased ovulation rate over 5-fold compared to that of controls (Table 1). In conclusion, we have shown that inhibin-based fecundity vaccines have the potential of increasing ovulation rates in the Malpura breed of sheep. Table 1

Inhibin immunoneutralization by antibodies raised against synthetic peptide sequences of inhibin α subunit: effects on gonadotrophin concentrations and ovulation rate in sheep

1990 ◽  
Vol 124 (1) ◽  
pp. 167-176 ◽  
Author(s):  
J. H. M. Wrathall ◽  
B. J. McLeod ◽  
R. G. Glencross ◽  
A. J. Beard ◽  
P. G. Knight
Keyword(s):  
Plasma Levels ◽  
Synthetic Peptide ◽  
Plasma Concentrations ◽  
Ovulation Rate ◽  
Control Groups ◽  
Α Subunit ◽  
Blood Samples ◽  
Antigenic Properties ◽  
N Terminus ◽  
The Mean

ABSTRACT Two experiments were conducted to explore the effectiveness of synthetic peptide-based vaccines for active and passive autoimmunization of sheep against inhibin. In the first experiment, adult Romney ewes (n = 20) were actively immunized against a synthetically produced peptide that corresponded to the N-terminus of the α-subunit of bovine inhibin (bIα(1–29)-Tyr30). This peptide was conjugated to tuberculin purified protein derivative (PPD) to increase its antigenic properties. Control groups comprised non-immunized (n = 10) and PPD-immunized (n = 10) ewes. Primary immunization (400 μg conjugate/ewe) was followed by two booster immunizations (200 μg conjugate/ewe), given 5 and 8 weeks later. Following synchronization of oestrus using progestagen sponges, ovulation rates were assessed by laparoscopy. Weekly blood samples were taken throughout the experiment. All inhibin-immunized ewes produced antibodies which bound 125I-labelled bovine inhibin (Mr 32 000), and ovulation rate in inhibin-immunized ewes (2·15 ± 0·22; mean ± s.e.m.) was significantly (P<0·01) greater than in both non-immunized (0·90 ± 0·23) and PPD-immunized (1·20 ± 0·13) control groups. Immunization against the peptide, but not against PPD alone, resulted in a modest rise in plasma FSH, with mean levels after the second boost being significantly (P<0·025) higher (22%) than those before immunization. Moreover, when blood samples were taken (2-h intervals) from randomly selected groups of control (n = 7) and inhibin-immunized (n = 7) ewes for an 84-h period following withdrawal of progestagen sponges, the mean plasma concentration of FSH during the 48 h immediately before the preovulatory LH surge was 37% greater (P< 0·025) in immunized than in control animals. However, more frequent blood sampling (every 15 min for 12 h) during follicular and mid-luteal phases of the oestrous cycle revealed no significant differences between treatment groups in mean plasma concentrations of FSH. In addition, neither mean concentrations of LH nor the frequency and amplitude of LH episodes differed between immunized and control ewes. However, the mean response of LH to a 2 μg bolus of gonadotrophin-releasing hormone, given during the luteal phase, was significantly (P<0·05) less in immunized than in control ewes. These findings indicate that active immunization of Romney ewes against a synthetic fragment of inhibin can promote a controlled increase in ovulation rate, but this response cannot be unequivocally related to an increase in plasma levels of FSH. In the second experiment, passive immunization of seasonally anoestrous ewes (mule × Suffolk crossbred; n = 6 per group) against inhibin, using an antiserum raised in sheep against a synthetic peptide corresponding to the N-terminus of the α-subunit of human inhibin promoted a rapid (<3 h), dose-dependent rise in plasma levels of FSH which remained increased (2·5-fold; P<0·001) for up to 30 h. Plasma concentrations of LH, however, were unaffected by treatment with the antiserum. It is deduced from this observation that, even in the seasonally anoestrous ewe, the ovary secretes physiologically active levels of inhibin, which exert an inhibitory action on the synthesis and secretion of FSH. Journal of Endocrinology (1990) 124, 167–176

Effect of active immunization of heifers against inhibin on plasma FSH concentrations, ovarian follicular development and ovulation rate

1992 ◽  
Vol 134 (1) ◽  
pp. 11-18 ◽  
Author(s):  
R. G. Glencross ◽  
E. C. L. Bleach ◽  
B. J. McLeod ◽  
A. J. Beard ◽  
P. G. Knight
Keyword(s):  
Synthetic Peptide ◽  
Ovarian Function ◽  
Statistical Significance ◽  
Follicular Development ◽  
Ovarian Response ◽  
Active Immunization ◽  
Ovulation Rate ◽  
Corpora Lutea ◽  
Α Subunit ◽  
Ovarian Follicular Development

ABSTRACT To study the effects of immunoneutralization of endogenous inhibin on gonadotrophin secretion and ovarian function, prepubertal heifers (n = 6) were actively immunized against a synthetic peptide replica of the N-terminal sequence of bovine inhibin α subunit bIα(1–29)Tyr30) coupled to ovalbumin. In contrast to ovalbumin-immunized controls (n=6), bIα(1–29)Tyr30-immunized heifers had detectable inhibin antibody titres (% binding to 125I-labelled bovine inhibin at 1:2000 dilution of plasma) of 17 ± 3% (s.e.m.) at puberty, rising to 31 ± 5% by the end of the study period 7 months later. Neither age (immunized: 295 ± 8 days; controls: 300 ± 5 days) nor body weight (immunized: 254 ± 13 kg; controls 251 ± 9 kg) at onset of puberty differed between groups. Although the difference did not reach statistical significance, mean plasma FSH concentrations recorded in inhibin-immunized heifers remained 35–40% higher than in controls throughout the 12-week period leading up to puberty (P = 0·14) and during nine successive oestrous cycles studied after puberty (P=0·10). Plasma LH concentrations did not differ between groups at any time during the study. Inhibin immunization had no effect on oestrous cycle length (immunized: 19·8±0·5 days; controls: 19·9±0·5 days). However, in comparison with controls, inhibinimmunized heifers had more medium sized (≥0·5 to <1 cm diameter) follicles during both the preovulatory (95%, P<0·001) and post-ovulatory (110%, P < 0·05 waves of follicular growth and more large (>1 cm diameter) follicles during the preovulatory wave (49%, P<0·05). In addition, the number of corpora lutea observed during the post-ovulatory phase of each cycle was significantly greater in the inhibin-immunized group (43%, P<0·01), as was the recorded incidence of cycles with multiple ovulations (19/56 in the inhibin-immunized group compared with 0/54 in controls; P<0·001). All six inhibinimmunized heifers had at least one cycle with multiple ovulation whereas none of the control heifers did so. These results support the conclusion that immunoneutralization of endogenous inhibin using a synthetic peptide-based vaccine can enhance ovarian follicular development and ovulation rate in heifers. Whether this ovarian response is dependent upon the expected increase in secretion of FSH remains to be established. Journal of Endocrinology (1992) 134, 11–18

scholarly journals Effects of re-immunization of heifers against inhibin on hormonal profiles and ovulation rate

Reproduction ◽  
2004 ◽  
Vol 128 (4) ◽  
pp. 475-482 ◽  
Author(s):  
M S Medan ◽  
S Akagi ◽  
H Kaneko ◽  
G Watanabe ◽  
C G Tsonis ◽  
...  
Keyword(s):  
Follicular Development ◽  
Peak Level ◽  
Ovarian Response ◽  
Ovulation Rate ◽  
Α Subunit ◽  
Oil Emulsion ◽  
Booster Injection ◽  
Hormonal Profiles ◽  
The Mean

To study the effect of re-immunization against inhibin on ovarian response and hormonal profiles, Japanese beef heifers (n = 5) were re-immunized three times with inhibin vaccine (recombinant ovine inhibin α-subunit in oil emulsion, 125 μg ml−1) one year after the primary immunization. Control heifers (n = 5) were injected with placebo (Montanide: Marcol adjuvant alone). Oestrous cycles were synchronized by using prostaglandin F2α (PGF2α) and ovarian response was monitored daily by ultrasonography. Blood samples were collected by jugular venipuncture for assessment of hormonal levels and inhibin antibody titres. In contrast to controls, inhibin re-immunized heifers generated antibodies against inhibin rapidly reaching a peak level 9 days after the first booster injection. The mean concentrations of FSH in re-immunized cows increased significantly in comparison with controls. In addition, there was a significant increase in oestradiol-17β and progesterone levels in re-immunized cows compared with controls. Inhibin re-immunized heifers had a significant increase in small (≥4 < 7 mm), medium (≥7 < 10 mm) and large (≥10 mm in diameter) sized follicles. Moreover, the mean ovulation rate was 5.0 ± 1.1 after the third booster injection in re-immunized heifers compared with control heifers (single ovulation). These results clearly demonstrate that re-immunization of inhibin can be used to enhance ovarian follicular development and ovulation rate. Furthermore, the great number of follicles is a potential source of oocytes that could be harvested for in vitro fertilization and embryo transfer programmes.

FSH causes a time-dependent stimulation of preovulatory follicle growth in the absence of pulsatile LH secretion in ewes chronically treated with gonadotrophin-releasing hormone agonist

1990 ◽  
Vol 126 (2) ◽  
pp. 297-307 ◽  
Author(s):  
H. M. Picton ◽  
C. G. Tsonis ◽  
A. S. McNeilly
Keyword(s):  
Plasma Concentration ◽  
Gnrh Agonist ◽  
Corpora Lutea ◽  
Preovulatory Follicle ◽  
Follicle Growth ◽  
Releasing Hormone ◽  
Gonadotrophin Releasing Hormone ◽  
The Mean ◽  
Stimulation Of

ABSTRACT The study investigated the relationship between the plasma concentration of FSH and the stimulation of preovulatory follicle growth in vivo in ewes chronically treated with the gonadotrophin-releasing hormone (GnRH) agonist buserelin (HOE 766). Welsh Mountain ewes with regular oestrous cycles were treated for 6 weeks with two discs implants placed s.c., each containing 5 mg of the agonist in a matrix of polyhydroxybutyric acid. Treatment with the agonist for 35 days produced a sustained suppression of the plasma concentration of FSH, stopped the pulsatile release of LH and prevented follicular development beyond 2·5 mm diameter. There was no difference between the total number of follicles > 1·0 mm diameter present in the ovaries of GnRH agonist-treated ewes and day 8 luteal phase control ewes. During the sixth week of agonist treatment ewes were infused with ovine FSH (6 μg NIADDK-oFSH16/h) in the presence of only basal concentrations of LH. After 24, 48, 72 or 120 h of FSH infusion, the mean number of follicles > 1 ·0 mm diameter per ewe was not significantly different between treated and control animals. Infusion of FSH caused a timedependent increase in (1) the number of follicles per ovary >2·5 mm, (2) the mean diameter of these follicles and (3) the proportion of the large follicles which could be classified as oestrogenic (> 3·7 nmol oestradiol/follicle per h in vitro). Injection of human chorionic gonadotrophin (750IU i.m.) after 120 h of FSH infusion caused the majority of these large follicles to ovulate and form apparently normal corpora lutea. These results indicate that, in the absence of pulsatile LH, FSH stimulates the growth of normal large oestrogenic follicles which, when stimulated, ovulate to produce viable corpora lutea. Journal of Endocrinology (1990) 126, 297–307

Effect of chronic FSH administration on ovarian follicular development, ovulation rate and corpora lutea formation in sheep

1993 ◽  
Vol 138 (2) ◽  
pp. 315-325 ◽  
Author(s):  
K. P. McNatty ◽  
N. L. Hudson ◽  
D. A. Heath ◽  
L. Shaw ◽  
L. Blay ◽  
...  
Keyword(s):  
Granulosa Cells ◽  
Plasma Concentrations ◽  
Ovulation Rate ◽  
Corpora Lutea ◽  
Aromatase Activity ◽  
Treatment Groups ◽  
Antral Follicles ◽  
Linear Relationships ◽  
The Mean

ABSTRACT This study in ewes examined the effects on ovarian function of a pulsatile regimen of ovine FSH (NIADDK-oFSH-17) administered over a 24- to 28-day period beginning on day 1 of the oestrous cycle (day 0 = oestrus). The FSH (1·66 μg or 5·00 μg) was administered i.v. over a 1-min interval once every hour throughout the treatment period. In other ewes ovine LH (NIDDK-oLH-23) was administered (10 μg once every 2 h) for 24–28 days together with oFSH (1·66 μg/h). Compared with untreated controls (n = 19 ewes), FSH alone at both doses (n = 19 ewes/dose) as well as the FSH +LH treatment (n=10) led to significant increases in the plasma concentrations of FSH (P <0·01), ovarian weight (P <0·05) and ovulation rate (P <0·01) but there was no change in the mean weight of individual corpora lutea (CL). Exogenous FSH at the high but not the low dose alone or with LH stimulated a significant overall increase in plasma inhibin concentrations (P <0·05). The geometric mean (and 95% confidence limits) ovulation rates in the high FSH (i.e. 5·00 μg/h), low FSH (i.e. 1·66 μg/h), low FSH+LH, and control treatment groups were 15·3 (9·3, 24·8), 3·7 (2·1, 6·0), 3·7 (2·5, 5·8) and 1·4 (1·2, 1·7) respectively. The FSH or FSH+LH treatments did not alter the total numbers of antral follicles (≥1 mm diameter). However, the high but not the low FSH or low FSH + LH treatment led to significant increases in the mean numbers of large follicles (i.e. >4·5 mm diameter; P<0·01) and a higher proportion of non-atretic antral follicles. Highly significant linear relationships were found between the mean plasma concentrations of FSH or inhibin and the ovulation rate (FSH: r=0·74, P<0·0001; inhibin: r=0·93, P<0·0001). Highly significant linear relationships were also found between the plasma concentrations of FSH or inhibin and the number of large follicles (i.e. >4·5 mm diameter; FSH, r=0·78, P<0·0001; inhibin, r=0·80, P<0·0001) and between the plasma concentrations of inhibin and the number of granulosa cells in large follicles (r=0·78, P<0·0001). After the high FSH but not the low FSH treatment there were significant increases in both FSH- and LH-induced responsiveness in granulosa cells with respect to cyclic AMP synthesis in vitro. In the high FSH treatment group, granulosa cells from 1–2·5 mm diameter follicles were responsive to LH whereas, in the low FSH or FSH + LH treatment groups and the controls, granulosa cells were not responsive to LH until the follicles were >4·5 mm in diameter. FSH or FSH+ LH treatment did not lead to increases in aromatase activity in granulosa cells (i.e. when expressed on a per cell basis) or to increases in oestradiol in follicular fluid. Collectively these results show that chronic increases in plasma FSH concentrations influence, in a dose–responsive manner, the size distribution of antral follicles, the proportion of non-atretic follicles, the number of follicles with peak aromatase activity and the ovulation rate, without altering the total number of antral follicles, the granulosa cell composition of individual follicles or the sizes of individual CL. Exogenous FSH treatment at high but not low doses enhanced the sensitivities of granulosa cells to both FSH and LH in vitro. Increases in plasma FSH also led to higher concentrations of plasma inhibin as a consequence of an increase in the number of large follicles and thus the number of granulosa cells. Journal of Endocrinology (1993) 138, 315–325

scholarly journals Active immunization against the proregions of GDF9 or BMP15 alters ovulation rate and litter size in mice

Reproduction ◽  
2012 ◽  
Vol 143 (2) ◽  
pp. 195-201 ◽  
Author(s):  
C Joy McIntosh ◽  
Steve Lawrence ◽  
Peter Smith ◽  
Jennifer L Juengel ◽  
Kenneth P McNatty
Keyword(s):  
Litter Size ◽  
Transforming Growth Factor ◽  
Transforming Growth Factor Β ◽  
Cross Reactivity ◽  
Full Length ◽  
Ovulation Rate ◽  
Corpora Lutea ◽  
Immunization Group

The transforming growth factor β (TGFB) superfamily proteins bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9), are essential for mammalian fertility. Recent in vitro evidence suggests that the proregions of mouse BMP15 and GDF9 interact with their mature proteins after secretion. In this study, we have actively immunized mice against these proregions to test the potential in vivo roles on fertility. Mice were immunized with either N- or C-terminus proregion peptides of BMP15 or GDF9, or a full-length GDF9 proregion protein, each conjugated to keyhole limpet hemocyanin (KLH). For each immunization group, ovaries were collected from ten mice for histology after immunization, while a further 20 mice were allowed to breed and litter sizes were counted. To link the ovulation and fertility data of these two experimental end points, mice were joined during the time period identified by histology as being the ovulatory period resulting in to the corpora lutea (CL) counted. Antibody titers in sera increased throughout the study period, with no cross-reactivity observed between BMP15 and GDF9 sera and antigens. Compared with KLH controls, mice immunized with the N-terminus BMP15 proregion peptide had ovaries with fewer CL (P<0.05) and produced smaller litters (P<0.05). In contrast, mice immunized with the full-length GDF9 proregion not only had more CL (P<0.01) but also had significantly smaller litter sizes (P<0.01). None of the treatments affected the number of antral follicles per ovary. These findings are consistent with the hypothesis that the proregions of BMP15 and GDF9, after secretion by the oocyte, have physiologically important roles in regulating ovulation rate and litter size in mice.

scholarly journals The Exon 46-Encoded Sequence Is Essential for Stability of Human Erythroid α-Spectrin and Heterodimer Formation

Blood ◽  
1997 ◽  
Vol 90 (10) ◽  
pp. 4188-4196 ◽  
Author(s):  
Rick Wilmotte ◽  
Sandra L. Harper ◽  
Jeanine A. Ursitti ◽  
Joëlle Maréchal ◽  
Jean Delaunay ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Cell Membranes ◽  
Peptide Sequence ◽  
Α Subunit ◽  
Recombinant Peptide ◽  
Alternative Mrna Splicing ◽  
Recombinant Peptides ◽  
Red Blood Cell Membranes

Abstract Human erythroid α-spectrin alleles responsible for hereditary elliptocytosis (αHE alleles) undergo increased incorporation into red blood cell membranes when the polymorphism αLELY (LELY: Low Expression LYon) occurs in trans. The αLELY polymorphism is characterized by a mutation in exon 40 at codon 1857 (CTA → GTA, Leu → Val) and the partial (50%) skipping of exon 46, which encodes residues 2177-2182 (Wilmotte et al, J Clin Invest 91:2091, 1993). Both of these peptide sequence alterations are located within the region of the α-chain involved in initiating heterodimer assembly, and either or both mutations could potentially contribute to decreased incorporation of α-chains from the αLELY allele in heterozygotes into red blood cell membranes. These possibilities were evaluated by testing the protease resistance and in vitro binding properties of normal and mutant recombinant 4-motif α subunit peptides containing the dimer initiation region. The two forms of α spectrin produced by alternative mRNA splicing of the αLELY allele were represented by α18-211857, a peptide with the codon 1857 mutation and retaining the exon 46 encoded sequence, and α18-211857-Δ46, a peptide carrying both the 1857 codon mutation and the exon 46 deletion. The properties of these two recombinant peptides were compared with α18-21, a peptide with the normal sequence at codon 1857 and retaining the exon 46 encoded sequence. The codon 1857 mutation does not adversely affect dimer formation, but it is responsible for the increased trypsin cleavage between the αIV and αV domains that was the characteristic feature initially used to identify the αLELY (SpαV/41) polymorphism (Alloisio et al, J Clin Invest 87:2169, 1991). Deletion of the six amino acids encoded by exon 46 perturbs folding of the α21 motif, because this region of the α18-211857-Δ46 peptide is rapidly degraded and this recombinant peptide is unusually prone to self-aggregation. Exon 46 deletion reduces, but does not eliminate, dimerization. Comparison of mild trypsin proteolytic products from an αLELY homozygote and the two αLELY recombinant peptides strongly suggests that little, if any, of the 50% of the α chains from the αLELY allele that contain the exon 46 deletion are incorporated into the mature erythroid membrane. Based on the in vitro analysis of recombinant αLELY peptides, the inability of detectable amounts of exon 46− α chains to assemble into the mature membrane skeleton in vivo is probably due to a combination of decreased dimer binding affinity and increased proteolytic degradation of these mutant chains.

DEVELOPMENT OF A TWO-SITE IMMUNORADIOMETRIC ASSAY FOR DIMERIC INHIBIN USING ANTIBODIES AGAINST CHEMICALLY SYNTHESIZED FRAGMENTS OF THE α AND β SUBUNIT

1991 ◽  
Vol 129 (2) ◽  
pp. R9-R12 ◽  
Author(s):  
P.G. Knight ◽  
N. Groome ◽  
A.J. Beard
Keyword(s):  
Synthetic Peptide ◽  
Peripheral Circulation ◽  
Cross Reaction ◽  
Immunoradiometric Assay ◽  
Ovarian Vein ◽  
In Vitro Bioassay ◽  
Α Subunit ◽  
N Terminus ◽  
Rat Ovary

ABSTRACT A two-site (liquid-phase) immunoradiometric assay (IRMA) for dimeric inhibin has been developed using antibodies raised against synthetic peptide sequences corresponding to the N-terminus (1-32) of the α subunit and the C-terminal region (82-114) of the βA subunit of Mr ∼30,000 human inhibin. Highly-purified Mr 32,000 bovine inhibin (standard) gave a dilution curve parallel to those for bovine follicular fluid (bFF), human (h)FF and rat ovary extract. Whilst the assay detected both Mr 56,000 and 32,000 inhibin forms in bFF, little reaction with higher Mr forms was evident. Cross-reaction of 'free' inhibin subunit (Mr 25,000 form) and recombinant human activin A in the IRMA were minimal (< 0.1 and < 2% respectively). Although the detection limit of the IRMA (∼ 50 pg/tube) was similar to that of several reported radioimmunoassays (RIA), the IRMA was unable to detect dimeric inhibin in jugular or utero-ovarian vein plasma of heifers. Similarly, when assayed by IRMA, bFF, hFF and rat ovary extract contained 8-58 times less inhibin than was indicated by RIA. These observations are consistent with earlier evidence that the ovary secretes a substantial excess of 'free' inhibin α subunit and that this material reaches the peripheral circulation. Surprisingly, however, the inhibin contents of bFF, hFF and rat ovary extract determined by in vitro bioassay were 8-23 times greater than the corresponding IRMA values, being similar to those derived by RIA. It is suggested that this quantitative discrepancy between inhibin contents estimated by IRMA and bioassay may be due to (1) loss of bioactivity of the inhibin standard during its purification and/or storage, (2) failure of the IRMA to detect high Mr forms of bioactive inhibin and/or (3) cross reaction of follistatin and other FSH-suppressing substances in the in vitro bioassay.

scholarly journals Ovarian characteristics in sheep with multiple fecundity genes

Reproduction ◽  
2017 ◽  
Vol 153 (2) ◽  
pp. 233-240 ◽  
Author(s):  
Kenneth P McNatty ◽  
Derek A Heath ◽  
Zaramasina Clark ◽  
Karen Reader ◽  
Jennifer L Juengel ◽  
...  
Keyword(s):  
Granulosa Cells ◽  
Total Mass ◽  
Total Cell ◽  
Ovulation Rate ◽  
Corpora Lutea ◽  
Preovulatory Follicles ◽  
Luteal Tissue ◽  
In The Wild ◽  
The Mean ◽  
The One

Ewes heterozygous for combinations of the Inverdale (FecXI; I+), Booroola (FecB; B+) and Woodlands (FecX2W; W+) mutations have ovulation rates higher than each mutation separately. The aims of the experiments described herein were to examine the ovarian phenotypes in I+B+ and I+B+W+ ewes and to compare these with the appropriate ++ (controls), I+ and BB animals available for this study. The mean ± s.e.m. ovulation rates in the ++ (n = 23), I+ (10), I+B+ (7), I+B+W+ (10) and BB (3) animals were 1.8 ± 0.1, 2.5 ± 0.2, 6.6 ± 1.0, 9.6 ± 0.9 and 9.7 ± 0.9 respectively. The maximum number of granulosa cells per follicle in the ++ and I+ genotypes was accumulated after exceeding 5 mm diameter, whereas in I+B+, I+B+W+ and BB animals, this was achieved when follicles reached >2–3 mm. The number of putative preovulatory follicles, as assessed from those with LH-responsive granulosa cells, 24 h after the induction of luteolysis, was higher (P < 0.01) in the I+B+ and I+B+W+ compared to the ++ and I+ genotypes. The median follicular diameters of these follicles in the ++, I+, I+B+, I+B+W+ and BB genotypes were 6, 5, 3, 3 and 3 mm respectively. The total number of granulosa cells in the putative preovulatory follicles when added together, and total mass of luteal tissue, did not differ between the genotypes. Thus, despite large ovulation rate differences between animals with one or more fecundity genes, the total cell compositions over all preovulatory follicles and corpora lutea, when added together, are similar to that from the one or two such follicles in the wild types.

Sign in / Sign up

Export Citation Format

Share Document